12-19-17 9:12 AM EST | Email Article


Vancouver, British Columbia / TheNewswire / December 19, 2017 – BioMark Diagnostics Inc. (“BioMark”) (CSE: BUX, FSE: 20B , OTC MKTS: BMKDF ) is proud to announce that the Canadian Government's established Going Global International (GGI) program has generously approved its second application to further engage with top tier Japanese institutions following its successful initial visit in June 2017. Based on continued favorable dialogue with established Japanese institutions BioMark has been invited back to Japan in the next 3 months.


President and CEO of BioMark, Mr. Bux says, “Our ultimate objective is to sign an agreement and commence collaborative research and commercialization activities with our highly proficient Japanese partners. BioMark is proud to acknowledge the generous financial and professional support provided by all levels of our government including International Trade, Canadian Trade Commission in Japan and BC and Trade Investment. Our synchronized federal and provincial government institutions have been an excellent example of a highly coordinated initiative designed to propel Canadian companies explore, shape their respective Japanese market entry strategy(ies) while leveraging our strong Canadian brand. We are hopeful to establish a viable and most importantly a sustainable footprint in Japan.  Japan is an important diagnostic oncology market especially for lung and stomach cancers. We believe with our potential Japanese partners we will collectively provide advanced cancer diagnostic solutions to improve patient care and positively impact patient outcome in Japan and globally.”


BioMark under its NDA with respective Japanese institutions has no liberty to disclose the entities at this present time.


About Going Global


The Going Global Innovation (GGI) program funded and managed by Global Affairs Canada is specifically designed to promote and enhance Canada's international innovation efforts. The program supports innovators who aim to commercialize technology by pursuing collaborative international research and development (R&D) opportunities through partnerships with key players in foreign markets.


About BC Trade and Investment


The B.C. Ministry of International Trade works with international enterprises to help them build strong links to the resources, skills and businesses that make British Columbia an attractive place to work and invest. 


The Ministry helps international companies invest in British Columbia and support international organizations who want to do business with British Columbia’s innovative and competitive manufacturers and service providers. 


The Ministry also offers assistance to export-ready firms in British Columbia through its dedicated team of trade and investment professionals in British Columbia, and its network of international Trade and Investment Representatives based in China, Japan, Korea, India, Southeast Asia, Europe, and the United States. 


About BioMark Diagnostics Inc.


BioMark is developing proprietary, non-invasive, and accurate cancer diagnostic solutions, which can help, detect, monitor and assess treatment for cancer early and cost effectively. The technology can also be used for measuring response to treatment and potentially for serial monitoring for cancer survivors.


Further information about BioMark is available under its profile on the SEDAR website: www.sedar.com and on the CSE website: http://thecse.com/

For further information on BioMark, please Contact:

Rashid Ahmed Bux

President & CEO

BioMark Diagnostics Inc.

Tel. 604-370-0779

Email: info@biomarkdiagnostics.com  

Copyright (c) 2017 TheNewswire - All rights reserved.

Add a Comment

Try Premium Membership today. Your first 14 days are free of charge. Start my Premium Membership Trial.
Sponsored Links
Buy a Link Now
Sponsor Center
Content Partners